Valuation Torrent Pharmaceuticals Limited

Stocks

Market Closed - Bombay S.E. 06:03:03 2026-09-11 EDT			5-day change	1st Jan Change
4,975.00 ^INR	+0.95%		+2.58%	+29.50%

09-08	India's Torrent Gas files updated IPO papers	RE
07-30	Torrent Pharmaceuticals Limited, Q1 2027 Earnings Call, Jul 30, 2026

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	473,197	520,309	880,347	1,094,736	1,428,460	1,892,330	-	-
Change	-	9.96%	69.2%	24.35%	30.48%	32.47%	-	-
Enterprise Value (EV) ¹	508,027	566,719	910,767	1,119,846	1,564,790	2,014,334	1,985,931	1,950,390
Change	-	11.55%	60.71%	22.96%	39.73%	28.73%	-1.41%	-1.79%
P/E	60.9x	57.4x	53.1x	57.3x	66x	73.9x	53.5x	43.1x
PBR	7.95x	8.4x	12.8x	14.4x	17x	13.2x	11.3x	9.78x
PEG	-	3.4x	0.6x	3.7x	5x	13.85x	1.4x	1.8x
Capitalization / Revenue	5.56x	5.41x	8.21x	9.51x	10.2x	9.55x	8.49x	7.58x
EV / Revenue	5.97x	5.89x	8.49x	9.72x	11.2x	10.2x	8.91x	7.81x
EV / EBITDA	20.9x	19.9x	27x	30.1x	34.3x	30.2x	25.5x	21.9x
EV / EBIT	28.7x	26.5x	34.4x	38.3x	45.5x	46.1x	36.7x	30.1x
EV / FCF	31.8x	31.6x	32.1x	56.7x	66.7x	51.2x	36.4x	32.2x
FCF Yield	3.15%	3.17%	3.11%	1.76%	1.5%	1.95%	2.75%	3.1%
Dividend per Share ²	16.5	22	28	32	38	32.7	38.18	46.78
Rate of return	1.18%	1.43%	1.08%	0.99%	0.9%	0.66%	0.77%	0.94%
EPS ²	22.96	26.79	48.94	56.47	63.92	67.33	92.92	115.4
Distribution rate	71.8%	82.1%	57.2%	56.7%	59.4%	48.6%	41.1%	40.5%
Net sales ¹	85,080	96,200	107,280	115,160	139,800	198,060	222,820	249,657
EBITDA ¹	24,310	28,420	33,680	37,210	45,590	66,600	77,800	89,023
EBIT ¹	17,690	21,350	26,480	29,260	34,400	43,718	54,154	64,773
Net income ¹	7,770	12,450	16,560	19,110	21,630	24,722	34,254	43,639
Net Debt ¹	34,830	46,410	30,420	25,110	136,330	122,003	93,601	58,060
Reference price ²	1,398.15	1,537.35	2,601.15	3,234.60	4,220.65	4,975.00	4,975.00	4,975.00
Nbr of stocks (in thousands)	338,445	338,445	338,445	338,445	338,445	380,368	-	-
Announcement Date	5/25/22	5/30/23	5/24/24	5/20/25	5/22/26	-	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
TORRENT PHARMACEUTICALS LIMITED	73.89x	10.17x	30.25x	0.66%	19.81B
ELI LILLY AND COMPANY	31.77x	11.54x	23.41x	0.62%	994B
JOHNSON & JOHNSON	29.54x	-	-	2.02%	640B
ABBVIE INC.	32.92x	7.63x	15.78x	2.67%	454B
ROCHE HOLDING AG	18.71x	4.57x	11.31x	2.91%	337B
NOVARTIS AG	19.41x	5.08x	12.59x	3.23%	261B
ASTRAZENECA PLC	20.34x	4.19x	11.96x	2.11%	246B
AMGEN INC.	23.87x	6.3x	11.23x	2.67%	204B
NOVO NORDISK A/S	12.3x	4.48x	9.37x	4.08%	190B
GILEAD SCIENCES, INC.	-43.47x	6.35x	24.81x	2.29%	178B
Average	21.93x	6.70x	16.74x	2.33%	352.46B
Weighted average by Cap.	23.48x	7.73x	17.19x	2.05%